Cresco Labs (CRLBF) Debt to Equity (2019 - 2025)

Cresco Labs (CRLBF) has disclosed Debt to Equity for 3 consecutive years, with $0.64 as the latest value for Q4 2021.

  • For the quarter ending Q4 2021, Debt to Equity rose 31.06% year-over-year to $0.64, compared with a TTM value of $0.64 through Dec 2021, up 31.06%, and an annual FY2021 reading of $0.64, up 31.06% over the prior year.
  • Debt to Equity was $0.64 for Q4 2021 at Cresco Labs, up from $0.49 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.64 in Q4 2021 and bottomed at $0.0 in Q4 2019.
  • Average Debt to Equity over 3 years is $0.38, with a median of $0.49 recorded in 2020.
  • The sharpest move saw Debt to Equity skyrocketed 16560.46% in 2020, then soared 31.06% in 2021.
  • Year by year, Debt to Equity stood at $0.0 in 2019, then surged by 16560.46% to $0.49 in 2020, then skyrocketed by 31.06% to $0.64 in 2021.
  • Business Quant data shows Debt to Equity for CRLBF at $0.64 in Q4 2021, $0.49 in Q4 2020, and $0.0 in Q4 2019.